These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31082624)

  • 41. [Solian: evaluation of 10 years' experimentation and clinical practice].
    Baldauf A; Metzger JY; Sichel JP
    Ann Med Psychol (Paris); 1988; 146(1-2):63-6. PubMed ID: 2901244
    [No Abstract]   [Full Text] [Related]  

  • 42. Psychosis in Parkinson's disease: therapeutic options.
    Hasnain M
    Drugs Today (Barc); 2011 May; 47(5):353-67. PubMed ID: 22013566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
    Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands].
    Vinkers CH; Sommer IE
    Tijdschr Psychiatr; 2015; 57(11):830-4. PubMed ID: 26552930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
    Höfer P; Friedrich F; Vyssoki B; Spindelegger C; Schmook M; Barnas C; Lesch OM; Walter H
    World J Biol Psychiatry; 2010 Aug; 11(5):759-61. PubMed ID: 20446883
    [No Abstract]   [Full Text] [Related]  

  • 46. [Amisulpride in Huntington's disease].
    Saft C; Andrich J; Kraus PH; Przuntek H
    Psychiatr Prax; 2005 Oct; 32(7):363-6. PubMed ID: 16220421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
    Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
    Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aripiprazole can treat psychotic features but not motor symptoms of Parkinson's disease: evidence from a SPECT study.
    Wu CL; Yang KC; Wang SJ; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):278-9. PubMed ID: 20854869
    [No Abstract]   [Full Text] [Related]  

  • 49. Clozapine with amisulpride for refractory schizophrenia.
    Agelink MW; Kavuk I; Ak I
    Am J Psychiatry; 2004 May; 161(5):924-5. PubMed ID: 15121665
    [No Abstract]   [Full Text] [Related]  

  • 50. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    Jagadheesan K; Muirhead D
    Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
    [No Abstract]   [Full Text] [Related]  

  • 51. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
    Barrimi M; El Ghazouani F; Zaimi O; Oneib B
    Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559
    [No Abstract]   [Full Text] [Related]  

  • 52. Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.
    Panchal SC; Ondo WG
    Curr Psychiatry Rep; 2018 Jan; 20(1):3. PubMed ID: 29374325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.
    Pintor L; Valldeoriola F; Baillés E; Martí MJ; Muñiz A; Tolosa E
    Clin Neuropharmacol; 2012; 35(2):61-6. PubMed ID: 22388466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of psychotic aspects of Parkinson's disease.
    Juncos JL
    J Clin Psychiatry; 1999; 60 Suppl 8():42-53. PubMed ID: 10335670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychotic disorder as a manifestation of Graves' disease.
    Katsigiannopoulos K; Georgiadou E; Pazarlis P; Karastergiou A; Papazisis G; Bozikas V; Garyfallos G
    Psychosomatics; 2010; 51(5):449-50. PubMed ID: 20833948
    [No Abstract]   [Full Text] [Related]  

  • 59. Risperidone and Parkinson's disease.
    Factor SA; Molho ES; Friedman JH
    Mov Disord; 2002 Jan; 17(1):221-2. PubMed ID: 11835472
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment options for depression and psychosis in Parkinson's disease.
    Poewe W; Seppi K
    J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.